Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 890 | 1101 | 890 | 1040 | 1106 | 1679 |
Fund Return | -11% | 10.13% | -11% | 1.32% | 2.03% | 5.32% |
Place in category | 424 | 1155 | 424 | 733 | 548 | 462 |
% in Category | 35 | 81 | 35 | 62 | 59 | 72 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Euromobiliare IF Multi Income I4 A | 482.34M | 6.41 | -0.32 | 1.51 | ||
Euromobiliare IF Multi Income I4 D | 197.23M | 6.41 | -0.34 | 1.50 | ||
Euromobiliare IF Multi Income I4 B | 7.11M | 8.13 | 1.15 | 2.58 | ||
Euromobiliare IF TR Flex Aggrssv A | 81.26M | 14.92 | 2.71 | - | ||
Euromobiliare IF TR Flex Aggrssv P | 15.95M | 15.21 | 3.41 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PF Euroland Equity I EUR DSA | 4.99B | 10.86 | 9.69 | 8.62 | ||
PF Euroland Equity I EUR ND | 4.99B | 10.86 | 9.68 | 8.62 | ||
LU1883304799 | 4.99B | 9.91 | 7.94 | - | ||
PF Euroland Equity J EUR ND | 4.99B | 10.99 | 9.89 | 8.80 | ||
Pioneer Funds Euroland Equity H EUR | 4.99B | 10.78 | 9.58 | 8.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 7.96 | 11,628.0 | +0.19% | |
Roche Holding Participation | CH0012032048 | 5.80 | 277.80 | -1.21% | |
Asl 2 C560 | NLEN02090954 | 4.50 | - | - | |
Novo Nordisk A/S Class B | DK0060534915 | 4.40 | - | - | |
Zurich Insurance Group | CH0011075394 | 4.27 | 523.20 | +0.85% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Buy | Sell |
Summary | Strong Sell | Neutral | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review